4dmedical Limited Stock Performance
| FDMDF Stock | USD 2.35 0.09 3.69% |
4DMedical holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.93, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 4DMedical will likely underperform. Use 4DMedical downside variance, day median price, and the relationship between the maximum drawdown and skewness , to analyze future returns on 4DMedical.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in 4DMedical Limited are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, 4DMedical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 80.9 M | |
| Total Cashflows From Investing Activities | -3.5 M |
4DMedical |
4DMedical Relative Risk vs. Return Landscape
If you would invest 112.00 in 4DMedical Limited on November 3, 2025 and sell it today you would earn a total of 123.00 from holding 4DMedical Limited or generate 109.82% return on investment over 90 days. 4DMedical Limited is currently producing 1.6517% returns and takes up 11.9658% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than 4DMedical, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
4DMedical Target Price Odds to finish over Current Price
The tendency of 4DMedical Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.35 | 90 days | 2.35 | about 24.35 |
Based on a normal probability distribution, the odds of 4DMedical to move above the current price in 90 days from now is about 24.35 (This 4DMedical Limited probability density function shows the probability of 4DMedical Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 2.93 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, 4DMedical will likely underperform. Moreover 4DMedical Limited has an alpha of 1.5394, implying that it can generate a 1.54 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). 4DMedical Price Density |
| Price |
Predictive Modules for 4DMedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 4DMedical Limited. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 4DMedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
4DMedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. 4DMedical is not an exception. The market had few large corrections towards the 4DMedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 4DMedical Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 4DMedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.54 | |
β | Beta against Dow Jones | 2.93 | |
σ | Overall volatility | 0.82 | |
Ir | Information ratio | 0.13 |
4DMedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 4DMedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 4DMedical Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| 4DMedical Limited is way too risky over 90 days horizon | |
| 4DMedical Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.05 M. Net Loss for the year was (24.59 M) with profit before overhead, payroll, taxes, and interest of 280.62 K. | |
| 4DMedical Limited has accumulated about 60.19 M in cash with (25.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 35.0% of the company shares are held by company insiders |
4DMedical Fundamentals Growth
4DMedical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of 4DMedical, and 4DMedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 4DMedical Pink Sheet performance.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (34.86) % | |||
| Current Valuation | 55.4 M | |||
| Shares Outstanding | 294.49 M | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 102.71 X | |||
| Revenue | 1.05 M | |||
| EBITDA | (35.25 M) | |||
| Cash And Equivalents | 60.19 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 1.3 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (25.27 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 74.31 M | |||
About 4DMedical Performance
By analyzing 4DMedical's fundamental ratios, stakeholders can gain valuable insights into 4DMedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 4DMedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 4DMedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.Things to note about 4DMedical Limited performance evaluation
Checking the ongoing alerts about 4DMedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for 4DMedical Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 4DMedical Limited is way too risky over 90 days horizon | |
| 4DMedical Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.05 M. Net Loss for the year was (24.59 M) with profit before overhead, payroll, taxes, and interest of 280.62 K. | |
| 4DMedical Limited has accumulated about 60.19 M in cash with (25.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 35.0% of the company shares are held by company insiders |
- Analyzing 4DMedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 4DMedical's stock is overvalued or undervalued compared to its peers.
- Examining 4DMedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 4DMedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 4DMedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 4DMedical's pink sheet. These opinions can provide insight into 4DMedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 4DMedical Pink Sheet analysis
When running 4DMedical's price analysis, check to measure 4DMedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4DMedical is operating at the current time. Most of 4DMedical's value examination focuses on studying past and present price action to predict the probability of 4DMedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4DMedical's price. Additionally, you may evaluate how the addition of 4DMedical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |